Steven Sandor - 02 Jun 2023 Form 4 Insider Report for BIOLASE, INC (BIOL)

Role
Chief Operating Officer
Signature
/s/ Michael C. Carroll, attorney-in-fact for Steven Sandor
Issuer symbol
BIOL
Transactions as of
02 Jun 2023
Net transactions value
$0
Form type
4
Filing time
06 Jun 2023, 20:37:20 UTC
Previous filing
12 Aug 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIOL Restricted Stock Unit Award $0 +58,000 +198% $0.000000 87,265 02 Jun 2023 Common Stock 58,000 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 At the option of the Company, each restricted stock unit represents the right to receive, at settlement, one share of common stock, or its cash equivalent.
F2 The restricted stock unit award vests as follows: (i) one-half of the restricted stock units shall vest on May 9, 2024, and (ii) one-half of the restricted stock units shall vest on May 9, 2025, subject to the Reporting Person's continued service with the Company.